News Headlines Article

F.D.A. Rejects Use of Drug in Cases of Breast Cancer
New York Times

The Food and Drug Administration on Thursday moved to revoke the approval of the widely used drug Avastin as a treatment for breast cancer, saying that new studies did not confirm that the medicine was helping patients. The decision is causing anguish for some women who worry they may no longer have access to a drug they believe is helping to keep them alive. But some patient advocacy groups welcomed the decision, saying Avastin had never been shown to prolong lives and that women with breast cancer need more than false hope.